References
Han AR, Lee HR, Park BB, et al. Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome. Ann Hematol 2007; 86: 493–8.
Wang H, Xiong L, Tang W, Zhou Y, Li F. A systematic review of malignancy-associated hemophagocytic lymphohistiocytosis that needs more attentions. Oncotarget 2017; 8: 59977–85.
Henter JI, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124–31.
Blom A, Beylot-Barry M, D’Incan M, Laroche L. Lymphoma-associated hemophagocytic syndrome (LAHS) in advanced-stage mycosis fungoides/Sézary syndrome cutaneous T-cell lymphoma. J Am Acad Dermatol 2011; 65: 404–10.
Lipsker D, Marquart-Elbaz C, Kurtz JE, Maloisel F, Heid E, Grosshans E. Macrophage activation syndrome disclosing leukemic transformation of mycosis fungoides. Ann Dermatol Venereol 1997; 124: 544–6.
Li F, Li P, Zhang R, et al. Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China. Med Oncol 2014; 31: 902–8.
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclosure
Conflicts of interest: none. Financial support: none.
About this article
Cite this article
Kitano, T., Nakao, M., Oishi, K. et al. A case of lymphoma-associated haemophagocytic syndrome in advanced-stage mycosis fungoides. Eur J Dermatol 30, 606–608 (2020). https://doi.org/10.1684/ejd.2020.3863
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2020.3863